ANAnne M. van Nifterick

Anne M. van Nifterick

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Anne M. van Nifterick has a total of 45 co-authors. Here are the top co-authors by number of shared publications:

  • Alida A. Gouw

    Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Clinical Neurophysiology and MEG Center, Neurology, De Boelelaan 1117, Amsterdam Netherlands

    5 shared publications
  • Alida A. Gouw

    Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, The Netherlands

    4 shared publications
  • Cornelis J. Stam

    Clinical Neurophysiology and MEG Center, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, The Netherlands

    4 shared publications
  • Cornelis Jan Stam

    Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Clinical Neurophysiology and MEG Center, Neurology, De Boelelaan 1117, Amsterdam Netherlands

    4 shared publications
  • Philip Scheltens

    Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc , 1081 HZ Amsterdam

    4 shared publications
  • Willem de Haan

    Alzheimer Center Amsterdam, Department of Neurology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands

    4 shared publications

Latest Publications

  • Open Access

    Replication and validation of two novel magnetoencephalography functional connectivity measures in Alzheimer’s disease

    by Elliz P. Scheijbeler, Milo Molleson, Deborah N. Schoonhoven, Anne M. van Nifterick, Arjan Hillebrand, Willem de Haan, Cornelis J. Stam, Alida A. Gouw

    Two novel magnetoencephalography (MEG) functional connectivity measures were recently shown to be superior to well-known measures of amplitude correlation and phase synchronization in detecting early stage neurophysiological abnormalities, particularly neuronal hyperexcitability, in a computational model of Alzheimer’s disease (AD). The reliability of these measures in empirical data remains to be evaluated. We investigated whether the Phase Lag Time (PLT) and Joint Permutation Entropy (JPE) could identify consistent patterns of between- and within-group functional connectivity in the theta (4–8 Hz), alpha (8–13 Hz), and beta (13–30 Hz) frequency bands in eyes-closed resting-state MEG recordings from two independent cohorts of AD patients (n = 28/n = 29) and control subjects (n = 29/n = 27). We assessed the classification performance of the measures and examined their construct validity using a computational approach. Results were compared with those obtained using two previously validated functional connectivity measures, the leakage-corrected Amplitude Envelope Correlation (AEC-c) and Phase Lag Index (PLI). In both cohorts, whole-brain analysis identified significant group differences (AD patients versus control subjects) in functional connectivity estimated by PLT and JPE across the theta and beta bands (effect sizes: 0.15–0.40; p < .05). Regional analysis revealed that 43–77 regions (out of 80) showed significant group differences in these frequency bands, with significant cross-cohort correlations between regional difference scores of rp = 0.37–0.55, p < .001. PLT and JPE connectivity matrices revealed strong within-group consistency across cohorts for both AD patients and control subjects in all frequency bands (rs > 0.80, p < .001). Logistic regression models trained on whole-brain PLT or JPE values in the theta or beta band achieved area under the curve values between 0.72 and 0.78. Finally, the PLT and JPE were shown to be sensitive to changes in coupling strength in a whole-brain computational model. Across all analyses, the PLT and JPE performed as well as, or better than, the AEC-c and PLI. The PLT and JPE can reliably detect neurophysiological abnormalities related to AD from eyes-closed resting-state MEG recordings. Since accumulating evidence identifies neuronal hyperexcitability as a key pathological process in early AD and a potential therapeutic target, these novel functional connectivity measures could play a valuable role in early disease detection and the evaluation of treatments aimed at restoring the excitation–inhibition balance in AD.

  • Open Access

    Unravelling excitation/inhibition imbalance in early and familial Alzheimer's Disease

    by Anne M van Nifterick

    Background: An early disruption in excitation‐inhibition (E‐I) balance is believed to underlie abnormal local and global network dynamics in Alzheimer’s disease (AD). While prior studies proposed that changes in E‐I balance may underlie the established slowing of oscillatory activity and changes in functional connectivity in symptomatic AD, the specific alterations occurring in the presymptomatic stage of AD remain poorly understood. This study aims to identify local and global spectral power and functional connectivity changes in individuals with familial AD before the onset of clinical symptoms.Method: Resting‐state magnetoencephalography (MEG) recordings were conducted in a unique cohort of cognitively unimpaired individuals carrying autosomal dominant mutations in the APP and PSEN1 genes (n = 11), leading to early‐onset AD. Each mutation carrier was demographically matched with three cognitively healthy subjects (HCs) without mutations and with available MEG. We compared source‐level whole‐brain average and regional spectral power and volume‐conduction corrected functional connectivity measures across different frequency bands. Hub vulnerability was assessed using the hub disruption index. Significant MEG measures were correlated with age, estimated years before symptom onset (EYBSO), and cognitive performance.Result: Cognitively normal mutation carriers exhibited signatures of oscillatory slowing, characterized by a widespread higher relative power in the theta band (4‐8 Hz) and a lower parieto‐temporal‐occipital peak frequency compared to HCs. Additionally, they presented frequency‐ and degree‐dependent functional connectivity changes: higher phase‐based functional connectivity in the theta band in initial low‐degree regions (as determined by weighted degree in HCs), but lower global amplitude‐based functional connectivity in the alpha (8‐13 Hz) and beta (13‐30 Hz) bands compared to HCs, most strongly in initial high‐degree regions. No correlations between MEG measures and age, EYBSO, or cognitive indices were found after correction for multiple comparisons.Conclusion: Neurophysiological changes occur before the onset of cognitive symptoms in individuals carrying mutations in the APP or PSEN1 genes. These changes include oscillatory slowing and frequency‐ and degree‐dependent functional connectivity alterations, mirroring alterations observed in clinical stages of AD and suggesting an early E‐I imbalance. These findings contribute to a comprehensive understanding of presymptomatic pathophysiological alterations in AD.


  • Open Access

    Functional network disruption in cognitively unimpaired autosomal dominant Alzheimer’s disease: a magnetoencephalography study

    by Anne M van Nifterick, Willem de Haan, Cornelis J Stam, Arjan Hillebrand, Philip Scheltens, Ronald E van Kesteren, Alida A Gouw

    Understanding the nature and onset of neurophysiological changes, and the selective vulnerability of central hub regions in the functional network, may aid in managing the growing impact of Alzheimer’s disease on society. However, the precise neurophysiological alterations occurring in the preclinical stage of human Alzheimer’s disease remain controversial. This study aims to provide increased insights on quantitative neurophysiological alterations during a true early-stage of Alzheimer’s disease. Using high spatial resolution source-reconstructed magnetoencephalography, we investigated regional and whole-brain neurophysiological changes in a unique cohort of 11 cognitively unimpaired individuals with pathogenic mutations in the presenilin-1 or amyloid precursor protein genes and a 1:3 matched control group (n = 33) with a median age of 49 years. We examined several quantitative magnetoencephalography measures that have been shown robust in detecting differences in sporadic Alzheimer’s disease patients and are sensitive to excitation-inhibition imbalance. This includes spectral power and functional connectivity in different frequency bands. We also investigated hub vulnerability using the hub disruption index. To understand how magnetoencephalography measures change as the disease progresses through its preclinical stage, correlations between magnetoencephalography outcomes and various clinical variables like age were analyzed. A comparison of spectral power between mutation carriers and controls revealed oscillatory slowing, characterized by widespread higher theta (4–8 Hz) power, a lower posterior peak frequency, and lower occipital alpha 2 (10–13 Hz) power. Functional connectivity analyses presented a lower whole-brain (amplitude-based) functional connectivity in the alpha (8–13 Hz) and beta (13–30 Hz) bands, predominantly located in parieto-temporal hub regions. Furthermore, we found a significant hub disruption index for (phase-based) functional connectivity in the theta band, attributed to both higher functional connectivity in “non-hub” regions alongside a hub disruption. Neurophysiological changes did not correlate with indicators of preclinical disease progression in mutation carriers after multiple comparisons correction. Our findings provide evidence that oscillatory slowing and functional connectivity differences occur before cognitive impairment in individuals with autosomal dominant mutations leading to early-onset Alzheimer’s disease. The nature and direction of these alterations are comparable to those observed in the clinical stages of Alzheimer’s disease, suggest an early excitation-inhibition imbalance, and fit with the activity-dependent functional degeneration hypothesis. These insights may prove useful for early diagnosis and intervention in the future.


  • Open Access

    Full complement activation is associated with capillary cerebral amyloid angiopathy in Alzheimer’s disease.

    by David Hondius, Robert Veerhuis, Ka Wan Li, Anne M van Nifterick, H. Bea Kuiperij, Marcel M. Verbeek, August B. Smit, Annemieke J.M. Rozemuller, Jeroen Hoozemans

    Background: Alzheimer’s disease is the most common form of dementia and mainly characterized by the accumulation the amyloid β (Aβ) peptide in the parenchyma and often around the blood vessels of the brain. The accumulation of Aβ in vessels walls is referred to as cerebral amyloid angiopathy (CAA). In a subset of AD cases CAA is observed in both capillaries and larger vessels which is designated as CAA type‐1. CAA type‐1 is associated with an increased neuroinflammatory response involving activated microglia and increased oxidative stress, which supposedly results in loss of blood‐brain barrier (BBB) integrity in CAA. Complement activation is an integral part of neuroinflammation associated with parenchymal Aβ deposits and CAA. However, a direct comparison of the complement activation in relation to plaque pathology and CAA type‐1 has not been made.Method: Using immunohistochemistry we performed a semi‐quantitative analysis on the expression and localization of complement factors C1q, C3, C4 and the membrane attack complex (MAC) in post mortem cortical brain tissue derived from AD cases with severe occurrence of CAA type‐1, AD cases without CAA and non‐demented control cases. In addition, label free quantitative mass spectrometry was applied to quantify complement components in whole cortical tissue lysates.Result: The complement factors C1q, C3 and C4 were found to be associated with CAA type‐1. No clear differences were observed in level of occurrence of C1q, C3 and C4 between AD cases with CAA type‐1, AD cases without CAA and non‐demented control cases. Interestingly, a subset of the AD cases with CAA type‐1 displayed MAC in affected vessels, whereas this was not observed in AD cases without CAA or control cases. Mass spectrometry analysis revealed an increase in C9, the primary component of MAC, in CAA type‐1 but not in AD without CAA.Conclusion: Early complement factors are present in all AD cases while the presence of MAC is restricted to a subset of CAA type‐1 cases, indicating full‐blown complement activation in CAA type‐1 but not in AD without CAA.


  • Open Access

    Neurophysiological alterations in mice and humans carrying mutations in APP and PSEN1 genes

    by Fran C van Heusden, Anne M van Nifterick, Bryan C. Souza, Arthur S.C. França, Cornelis J Stam, Philip Scheltens, August B. Smit, Alida A Gouw, Ronald E. van Kesteren

    Background: Studies in animal models of Alzheimer’s disease (AD) have provided valuable insights into the molecular and cellular processes underlying neuronal network dysfunction, but whether and how AD‐related neurophysiological alterations translate between mice and men remains uncertain.Method: We characterized neurophysiological alterations in mice and humans carrying AD mutations in the APP and/or PSEN1 genes, focusing on early changes. Longitudinal local field potential recordings were peformed in 3‐12‐month‐old APP/PS1 mice and cross‐sectional magnetoencephalography recordings in pre‐symptomatic human APP and PSEN1 mutation carriers. Recordings were acquired of the left hippocampus, frontal and parietal cortex. We performed spectral activity and functional connectivity analyses and results were compared with wildtype control mice and healthy age‐matched human subjects.Result: APP/PS1 mice showed increased aboslute power, especially at higher frequencies (beta and gamma) and predominantly between 3 and 6 months of age. Relative power showed an overall shift from lower to higher fequencies over almost the entire recording period and across all three brain regions. There was a trend for reduced peak frequency in APP/PS1 mice at 3‐4 months of age. Human mutation carriers did not show changes in power except for an increase in relative theta power in the hippocampus. Parietal cortex and hippocampal peak frequency were reduced in human mutation carriers. In both models, significant alteration in functional connectivity were detected in theta, alpha, beta and gamma frequency bands, but the exact frequency range and direction of change differed for APP/PS1 mice and human mutation carriers (Table 1).Conclusion: In conclusion, both mice and humans carrying APP and/or PSEN1 mutations show abnormal neurophysiological activity, but several measures do not translate one‐to‐one between species. Alterations in spectral characteristics and functional connectivity in mice should be interpreted with care and may be due to overexpression of amyloid in combination with absence of tau pathology in cholinergic degeneration. Future studies should explore whether changes in brain activity in other AD mouse models provide better translation to the human AD continuum.

  • Open Access

    Hub vulnerability and short path length to entorhinal cortex are associated with tau binding in Alzheimer’s disease: a combined MEG/PET study

    by Deborah N Schoonhoven, Ana P Millan, Emma M. Coomans, Maqsood Yaqub, Anne M van Nifterick, Denise Visser, Rik Ossenkoppele, Hayel Tuncel, Wiesje M. van der Flier, Willem de Haan, et al.

    Background: Brain network studies have revealed that highly connected ‘hub’ regions are particularly vulnerable to Alzheimer’s disease (AD) pathology. Additionally, the ‘‘transneuronal spread” hypothesis proposes that a toxic agent (tau) propagates along shortest paths through functionally connected neurons, driven by aberrant neuronal activity. We investigate whether network characteristics as determined using magnetoencephalography (MEG) are correlated to tau pathology in the different stages of AD.Method: We analysed source‐reconstructed MEG data and dynamic 100‐minutes [18F]flortaucipir PET from 57 subjects positive for amyloid‐beta (Aβ)‐pathology (preclinical AD (n = 16)), mild cognitive impairment (MCI (n = 16)) and AD dementia (n = 25)). Cognitively healthy subjects without Aβ‐pathology were included as controls (n = 25). For each subject, we obtained a network based on the alpha band amplitude envelope correlation (AEC‐c, 8‐13Hz), and theta band phase lag index (PLI, 4‐8Hz), based on the Brainnettome atlas. For each node in the network, we obtained the following measures: weighted degree, degree, betweenness centrality, eccentricity (as measures of hubness); distance to left entorhinal cortex (measure of shortest path/transneuronal spread); hub disruption index for all previous hubness measures (selective hub damage) and [18F]flortaucipir BPND. Pearson’s correlations were calculated between group averages of network measures and tau‐PET binding (FDR‐corrected). Furthermore, we analysed whether network measures of the previous disease stage correlated with [18F]flortaucipir retention in the subsequent disease stage.Result: Hub regions were predominantly found in the temporal areas (Fig‐1). Higher ‘hubness’ and shorter neuronal distance to epicentre were associated to higher tau binding in all stages of the AD continuum (Fig‐2a). Disproportional disruption to hub regions in the AEC‐c alpha band was associated with increased tau binding, but the opposite effect was found for the PLI theta band (Fig‐2b). Finally, high weighted degree, degree, and betweenness centrality in the preceding disease stage were correlated with increased tau binding in subsequent disease stages (Fig‐2c).Conclusion: Hub regions and transneuronal spreading are key mechanisms in the propagation of tau pathology across the AD brain. Furthermore, hubs are particularly vulnerable to tau. The insight that high neuronal activity might play a causal role in Alzheimer’s disease can have implications for early detection and interventional strategies.

  • Open Access

    Local signal variability and functional connectivity: Sensitive measures of the excitation-inhibition ratio?

    by Anne M. van Nifterick, Elliz P. Scheijbeler, Alida A. Gouw, Willem de Haan, Cornelis J. Stam

    A novel network version of permutation entropy, the inverted joint permutation entropy (JPEinv), holds potential as non-invasive biomarker of abnormal excitation-inhibition (E-I) ratio in Alzheimer’s disease (AD). In this computational modelling study, we test the hypotheses that this metric, and related measures of signal variability and functional connectivity, are sensitive to altered E-I ratios. The E-I ratio in each neural mass of a whole-brain computational network model was systematically varied. We evaluated whether JPEinv, local signal variability (by permutation entropy) and functional connectivity (by weighted symbolic mutual information (wsMI)) were related to E-I ratio, on whole-brain and regional level. The hub disruption index can identify regions primarily affected in terms of functional connectivity strength (or: degree) by the altered E-I ratios. Analyses were performed for a range of coupling strengths, filter and time-delay settings. On whole-brain level, higher E-I ratios were associated with higher functional connectivity (by JPEinv and wsMI) and lower local signal variability. These relationships were nonlinear and depended on the coupling strength, filter and time-delay settings. On regional level, hub-like regions showed a selective decrease in functional degree (by JPEinv and wsMI) upon a lower E-I ratio, and non-hub-like regions showed a selective increase in degree upon a higher E-I ratio. These results suggest that abnormal functional connectivity and signal variability, as previously reported in patients across the AD continuum, can inform us about altered E-I ratios.


  • Open Access

    Network Hyperexcitability in Early Alzheimer’s Disease: Is Functional Connectivity a Potential Biomarker?

    by C. J. Stam, A. M. van Nifterick, W. de Haan, A. A. Gouw

    Network hyperexcitability (NH) is an important feature of the pathophysiology of Alzheimer’s disease. Functional connectivity (FC) of brain networks has been proposed as a potential biomarker for NH. Here we use a whole brain computational model and resting-state MEG recordings to investigate the relation between hyperexcitability and FC. Oscillatory brain activity was simulated with a Stuart Landau model on a network of 78 interconnected brain regions. FC was quantified with amplitude envelope correlation (AEC) and phase coherence (PC). MEG was recorded in 18 subjects with subjective cognitive decline (SCD) and 18 subjects with mild cognitive impairment (MCI). Functional connectivity was determined with the corrected AECc and phase lag index (PLI), in the 4–8 Hz and the 8–13 Hz bands. The excitation/inhibition balance in the model had a strong effect on both AEC and PC. This effect was different for AEC and PC, and was influenced by structural coupling strength and frequency band. Empirical FC matrices of SCD and MCI showed a good correlation with model FC for AEC, but less so for PC. For AEC the fit was best in the hyperexcitable range. We conclude that FC is sensitive to changes in E/I balance. The AEC was more sensitive than the PLI, and results were better for the thetaband than the alpha band. This conclusion was supported by fitting the model to empirical data. Our study justifies the use of functional connectivity measures as surrogate markers for E/I balance.


  • Top Cited Papers
    Open Access

    Resting-state oscillations reveal disturbed excitation–inhibition ratio in Alzheimer’s disease patients

    by Anne M. van Nifterick, Danique Mulder, Denise J. Duineveld, Marina Diachenko, Philip Scheltens, Cornelis J. Stam, Ronald E. van Kesteren, Klaus Linkenkaer-Hansen, Arjan Hillebrand, Alida A. Gouw

    An early disruption of neuronal excitation–inhibition (E–I) balance in preclinical animal models of Alzheimer’s disease (AD) has been frequently reported, but is difficult to measure directly and non-invasively in humans. Here, we examined known and novel neurophysiological measures sensitive to E–I in patients across the AD continuum. Resting-state magnetoencephalography (MEG) data of 86 amyloid-biomarker-confirmed subjects across the AD continuum (17 patients diagnosed with subjective cognitive decline, 18 with mild cognitive impairment (MCI) and 51 with dementia due to probable AD (AD dementia)), 46 healthy elderly and 20 young control subjects were reconstructed to source-space. E–I balance was investigated by detrended fluctuation analysis (DFA), a functional E/I (fE/I) algorithm, and the aperiodic exponent of the power spectrum. We found a disrupted E–I ratio in AD dementia patients specifically, by a lower DFA, and a shift towards higher excitation, by a higher fE/I and a lower aperiodic exponent. Healthy subjects showed lower fE/I ratios (< 1.0) than reported in previous literature, not explained by age or choice of an arbitrary threshold parameter, which warrants caution in interpretation of fE/I results. Correlation analyses showed that a lower DFA (E–I imbalance) and a lower aperiodic exponent (more excitation) was associated with a worse cognitive score in AD dementia patients. In contrast, a higher DFA in the hippocampi of MCI patients was associated with a worse cognitive score. This MEG-study showed E–I imbalance, likely due to increased excitation, in AD dementia, but not in early stage AD patients. To accurately determine the direction of shift in E–I balance, validations of the currently used markers and additional in vivo markers of E–I are required.


  • Open Access

    A multiscale brain network model links Alzheimer’s disease-mediated neuronal hyperactivity to large-scale oscillatory slowing

    by Anne M. van Nifterick, Alida A. Gouw, Ronald E. van Kesteren, Philip Scheltens, Cornelis J. Stam, Willem de Haan

    Background: Neuronal hyperexcitability and inhibitory interneuron dysfunction are frequently observed in preclinical animal models of Alzheimer’s disease (AD). This study investigates whether these microscale abnormalities explain characteristic large-scale magnetoencephalography (MEG) activity in human early-stage AD patients.Methods: To simulate spontaneous electrophysiological activity, we used a whole-brain computational network model comprised of 78 neural masses coupled according to human structural brain topology. We modified relevant model parameters to simulate six literature-based cellular scenarios of AD and compare them to one healthy and six contrast (non-AD-like) scenarios. The parameters include excitability, postsynaptic potentials, and coupling strength of excitatory and inhibitory neuronal populations. Whole-brain spike density and spectral power analyses of the simulated data reveal mechanisms of neuronal hyperactivity that lead to oscillatory changes similar to those observed in MEG data of 18 human prodromal AD patients compared to 18 age-matched subjects with subjective cognitive decline.Results: All but one of the AD-like scenarios showed higher spike density levels, and all but one of these scenarios had a lower peak frequency, higher spectral power in slower (theta, 4–8Hz) frequencies, and greater total power. Non-AD-like scenarios showed opposite patterns mainly, including reduced spike density and faster oscillatory activity. Human AD patients showed oscillatory slowing (i.e., higher relative power in the theta band mainly), a trend for lower peak frequency and higher total power compared to controls. Combining model and human data, the findings indicate that neuronal hyperactivity can lead to oscillatory slowing, likely due to hyperexcitation (by hyperexcitability of pyramidal neurons or greater long-range excitatory coupling) and/or disinhibition (by reduced excitability of inhibitory interneurons or weaker local inhibitory coupling strength) in early AD.Conclusions: Using a computational brain network model, we link findings from different scales and models and support the hypothesis of early-stage neuronal hyperactivity underlying E/I imbalance and whole-brain network dysfunction in prodromal AD.